How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Sekisui Diagnostics P.E.I. Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
6 clearance records and 2 recall records in the covered releases, across 1 source company names and 6 product codes. Dated history runs from Dec 2, 2011 to Feb 18, 2022.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| LDP · Colorimetry, Acetaminophen | 2 | 1 |
| CGS · Nad Reduction/Nadh Oxidation, Cpk Or Isoenzymes | 1 | 0 |
| JGJ · Photometric Method, Magnesium | 1 | 0 |
| JIF · Enzymatic Method, Ammonia | 0 | 1 |
| JIT · Calibrator, Secondary | 1 | 0 |
| PDJ · Hemoglobin A1c Test System | 1 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| AcetaminophenK202644 · LDP | Sekisui Diagnostics P.E.I., Inc. | 510(k) | Feb 18, 2022FDA decision date |
| SEKURE Creatine Kinase AssayK182702 · CGS | Sekisui Diagnostics P.E.I., Inc. | 510(k) | Apr 17, 2019FDA decision date |
| SEKURE Acetaminophen L3K AssayK180835 · LDP | Sekisui Diagnostics P.E.I., Inc. | 510(k) | Feb 8, 2019FDA decision date |
| SEKURE HbA1c AssayK173206 · PDJ | Sekisui Diagnostics P.E.I., Inc. | 510(k) | Jul 12, 2018FDA decision date |
| Sekisui Diagnostics Ammonia L3K Assay; Catalog Number: 293-80-91 and 293-10 For the IN VITRO quantitative measurement of ammonia concentration in…Z-1078-2017 · JIF | Sekisui Diagnostics P.E.I. Inc. | Recall | Jan 23, 2017FDA classification date |
| DC-UIBC-CALK163078 · JIT | Sekisui Diagnostics P.E.I., Inc. | 510(k) | Dec 8, 2016FDA decision date |
| Sekure Chemistry Sekisui Diagnostics Acetaminophen L3K Assay, In-vitro Diagnostic Catalog Number: 506-10: R1: 1 x 10ml, R2: 2 x 10ml Catalog Num…Z-1171-2016 · LDP | Sekisui Diagnostics P.E.I. Inc. | Recall | Mar 14, 2016FDA record creation date |
| MAGNESIUM ASSAYK111915 · JGJ | Sekisui Diagnostics P.E.I., Inc. | 510(k) | Dec 2, 2011FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.